desethyloxybutynin has been researched along with solifenacin succinate in 1 studies
| Studies (desethyloxybutynin) | Trials (desethyloxybutynin) | Recent Studies (post-2010) (desethyloxybutynin) | Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) |
|---|---|---|---|---|---|
| 38 | 12 | 6 | 522 | 194 | 343 |
| Protein | Taxonomy | desethyloxybutynin (IC50) | solifenacin succinate (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.5737 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0635 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.1308 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, K; Oki, T; Sato, S; Yamada, S | 1 |
1 other study(ies) available for desethyloxybutynin and solifenacin succinate
| Article | Year |
|---|---|
Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Topics: Administration, Oral; Animals; Depression, Chemical; In Vitro Techniques; Male; Mandelic Acids; Mice; Muscarinic Antagonists; Quinuclidines; Radioligand Assay; Receptors, Muscarinic; Salivary Glands; Salivation; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder | 2005 |